Umbilical cord hernia mimicking a cord teratoma.
El-Messidi A., Fung KFK.
Case Report / Series, published in J Obstet Gynaecol Can (2009) — summary generated from the PubMed abstract.
Early human evidence such as case series or small samples is exploring possible benefits.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Case Report / Series
- Journal
- J Obstet Gynaecol Can (2009)
- Country
- Netherlands
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 19646319
- DOI
- 10.1016/S1701-2163(16)34216-5
Abstract (original English)
Most umbilical cord masses detected by sonography are angiomyxomas, hematomas, or teratomas. Cord teratomas arise from totipotent stem cells and contain tissue from the three germ-cell layers. Tumour components are foreign to surrounding tissue and may have a polymorphic presentation. We report a case of a suspected umbilical cord teratoma, identified by sonographic and magnetic resonance imaging, which in fact camouflaged an umbilical cord hernia. The natural history of an omphalocele and umbilical cord hernia dictates the presence of such anterior abdominal wall defects by approximately 12 weeks' gestation, once the gut returns from the peritoneal space within the umbilical stalk to the peritoneal cavity. Adipose tissue is not described as a classic finding in an omphalocele or umbilical cord hernia. Our case of umbilical cord hernia is the first described as strictly distal to, and not contained within, the abdominal wall cord insertion site, and to contain fat, thereby mimicking a cord teratoma.
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • Without an adequate control group, treatment effects cannot be separated from other factors.
Evidence level
Early human evidence such as case series or small samples is exploring possible benefits.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.